The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome
The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome
复制标题
鱼油脂肪乳对短肠综合征大鼠模型肠衰竭相关肝病的保护作用
DOI:
10.1007/s00383-017-4190-4
复制
发表时间:
2017
影响因子:
1.8
通讯作者:
Ieiri Satoshi
中科院分区:
文献类型:
--
作者:
Machigashira Seiro;Kaji Tatsuru;Onishi Shun;Yamada Waka;Yano Keisuke;Yamada Koji;Masuya Ryuta;Kawano Takafumi;Nakame Kazuhiko;Mukai Motoi;Ieiri Satoshi
PurposePediatric patients with intestinal failure need long-term parenteral nutrition (PN), but this nutritional support causes liver dysfunction, such as intestinal failure-associated liver disease (IFALD). Several studies have shown that the lipid emulsion produced by soybean oil (SO) is associated with the occurrence of IFALD. In this study, we evaluated the effect of SO and fish oil (FO) lipid emulsion on hepatic steatosis.MethodsSprague-Dawley rats underwent jugular vein catheterization and were divided into three groups: sham operation with normal chow (Sham group), 80% small bowel resection (80% SBR) + TPN with SO lipid emulsion (SO group), and 80% SBR + TPN with FO lipid emulsion (FO group). All rats were euthanized and the serum biochemistry and hepatic histology analyzed.ResultsNo significant differences in the serum liver or biliary enzymes were noted between the SO and FO groups. The pathological findings and NAFLD score in the FO group did not show steatosis and were significantly lower than in the SO group. An analysis of the fatty acids profile in the both the SO and FO groups did not indicate essential fatty acid deficiency (EFAD).ConclusionFO lipid emulsion may have a protective role against steatosis of IFALD without EFAD.